Prudo-Chlebosz Raymond
Reporting owner on Forms 3, 4 and 5, CIK 1653262.
Prudo-Chlebosz Raymond reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-16.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AKTX · Akari Therapeutics PlcCIK 1541157 | director | 1 | 2026-10-16 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-10-05 | A granted | +3,240 | $7.899 | 76,861 | Form 4 |
| AKTX · Akari Therapeutics PlcAmerican Depositary Shares representing… | 2026-08-18 | A granted | +9,072 | $7.899 | 73,621 | Form 4 |
| AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative | 2026-08-18 | A granted | +30,000 | $0 | 30,000 | Form 4 |
| AKTX · Akari Therapeutics PlcStock Option (Right to Buy), derivative | 2026-08-18 | A granted | +15,000 | $0 | 15,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001493152-26-047458 | Akari Therapeutics Plc | 2026-10-16 |